TD Cowen Trims Elevance Health (NYSE:ELV) Target Price to $589.00
Elevance Health (NYSE:ELV – Free Report) had its price objective decreased by TD Cowen from $624.00 to $589.00 in a research report released on Friday morning, Benzinga reports. TD Cowen currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the company. Truist Financial lifted their target […]
More Stories
FS KKR Capital Corp. (NYSE:FSK) Shares Purchased by Truvestments Capital LLC
Truvestments Capital LLC grew its position in shares of FS KKR Capital Corp. (NYSE:FSK – Free Report) by 3.6% during...
80,226 Shares in Invesco S&P 500 Top 50 ETF (NYSEARCA:XLG) Bought by Truvestments Capital LLC
Truvestments Capital LLC acquired a new stake in Invesco S&P 500 Top 50 ETF (NYSEARCA:XLG – Free Report) during the...
Truvestments Capital LLC Boosts Stake in Powell Industries, Inc. (NASDAQ:POWL)
Truvestments Capital LLC increased its holdings in Powell Industries, Inc. (NASDAQ:POWL – Free Report) by 14.6% during the 3rd quarter,...
TopBuild Corp. (NYSE:BLD) Stock Position Raised by Truvestments Capital LLC
Truvestments Capital LLC raised its stake in TopBuild Corp. (NYSE:BLD – Free Report) by 14.0% during the third quarter, according...
United Rentals, Inc. (NYSE:URI) Shares Purchased by Independent Advisor Alliance
Independent Advisor Alliance lifted its position in shares of United Rentals, Inc. (NYSE:URI – Free Report) by 5.6% in the...
Tetra Tech, Inc. Plans Quarterly Dividend of $0.06 (NASDAQ:TTEK)
Tetra Tech, Inc. (NASDAQ:TTEK – Get Free Report) declared a quarterly dividend on Monday, November 11th,Wall Street Journal reports. Stockholders...